Could this have something to do with the FDA or perhaps the Wild Card? hmmm
UNITED STATES SECURITIES AND EXCHANGE COMMISSION March 6, 2014
ORDER GRANTING CONFIDENTIAL TREATMENT UNDER THE SECURITIES EXCHANGE ACT OF 1934 22nd Century Group, Inc.
File No. 000-54111 - CF#30617 _____________________
22nd Century Group, Inc. submitted an application under Rule 24b-2 requesting confidential treatment for information it excluded from the Exhibits to a Form 10-K filed on January 30, 2014. Based on representations by 22nd Century Group, Inc. that this information qualifies as confidential commercial or financial information under the Freedom of Information Act, 5 U.S.C. 552(b)(4), the Division of Corporation Finance has determined not to publicly disclose it. Accordingly, excluded information from the following exhibit will not be released to the public for the time period specified:
Exhibit 10.12 through October 1, 2017 For the Commission, by the Division of Corporation Finance, pursuant to delegated authority:
Elizabeth M. Murphy Secretary